Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation

MLA

Karin Voit-Bak, et al. Extracorporeal Apheresis Therapy for Alzheimer Disease-Targeting Lipids, Stress, and Inflammation. Jan. 2020. EBSCOhost, https://doi.org/10.1038/s41380-019-0542-x.

APA

Karin Voit-Bak, Stefan R. Bornstein, Ulrike Schatz, Julio Licinio, Sandrine Thuret, Bernhard O. Boehm, George P. Chrousos, Richard Straube, Andrew V. Schally, Sergey Tselmin, Gerd Kempermann, Ma-Li Wong, Heinz Reichmann, Peter Rosenthal, & Ulrich Julius. (2020). Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation. https://doi.org/10.1038/s41380-019-0542-x

Chicago

Karin Voit-Bak, Stefan R. Bornstein, Ulrike Schatz, Julio Licinio, Sandrine Thuret, Bernhard O. Boehm, George P. Chrousos, et al. 2020. “Extracorporeal Apheresis Therapy for Alzheimer Disease-Targeting Lipids, Stress, and Inflammation,” January. doi:10.1038/s41380-019-0542-x.